Press Releases

and/or
543 News Releases found
Physician reviewing electronic medical records.
Memorial Sloan Kettering Cancer Center Selects Epic to Transform Electronic Health Record System

Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.
Lawrence Schwartz, MD
Memorial Sloan Kettering Cancer Center Names Lawrence Schwartz, MD, New Chair of the Department of Radiology

Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging, artificial intelligence in cancer imaging, and for his pioneering work in the development and validation of novel imaging biomarkers in oncology.
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
A Fred's Team runner
Fred's Team Makes History by Raising $100 Million for Cancer Research

Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.
Eli L. Diamond, MD and Omar Abdel-Wahab, MD
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.
MSK Awards & Appointments October 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
Carol Morris, MD, MS
Carol Morris Named Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center

Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK).
Left to right: Eileen M. O'Reilly, MD, Christine A. Iacobuzio-Donahue, MD, PhD
Memorial Sloan Kettering Cancer Center Receives NCI SPORE Grant to Improve Outcomes for Patients with Pancreatic Cancer

Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the National Cancer Institute (NCI).
Sloan Kettering Institute’s Alexander Gitlin
Sloan Kettering Institute’s Alexander Gitlin Honored with Prestigious NIH Director’s Early Independence Award

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.
MSK Awards & Appointments September 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: